1. Home
  2. RLAY vs ETD Comparison

RLAY vs ETD Comparison

Compare RLAY & ETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • ETD
  • Stock Information
  • Founded
  • RLAY 2015
  • ETD 1932
  • Country
  • RLAY United States
  • ETD United States
  • Employees
  • RLAY N/A
  • ETD N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • ETD Home Furnishings
  • Sector
  • RLAY Health Care
  • ETD Consumer Discretionary
  • Exchange
  • RLAY Nasdaq
  • ETD Nasdaq
  • Market Cap
  • RLAY 803.4M
  • ETD 763.7M
  • IPO Year
  • RLAY 2020
  • ETD 1993
  • Fundamental
  • Price
  • RLAY $5.48
  • ETD $28.91
  • Analyst Decision
  • RLAY Strong Buy
  • ETD Hold
  • Analyst Count
  • RLAY 8
  • ETD 2
  • Target Price
  • RLAY $17.25
  • ETD $30.00
  • AVG Volume (30 Days)
  • RLAY 1.6M
  • ETD 275.5K
  • Earning Date
  • RLAY 11-05-2025
  • ETD 10-29-2025
  • Dividend Yield
  • RLAY N/A
  • ETD 6.26%
  • EPS Growth
  • RLAY N/A
  • ETD N/A
  • EPS
  • RLAY N/A
  • ETD 2.01
  • Revenue
  • RLAY $8,355,000.00
  • ETD $614,649,000.00
  • Revenue This Year
  • RLAY $27.33
  • ETD $1.12
  • Revenue Next Year
  • RLAY $8.87
  • ETD $3.79
  • P/E Ratio
  • RLAY N/A
  • ETD $14.39
  • Revenue Growth
  • RLAY N/A
  • ETD N/A
  • 52 Week Low
  • RLAY $1.78
  • ETD $24.55
  • 52 Week High
  • RLAY $7.07
  • ETD $32.61
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 75.63
  • ETD 46.34
  • Support Level
  • RLAY $5.17
  • ETD $28.43
  • Resistance Level
  • RLAY $5.42
  • ETD $29.61
  • Average True Range (ATR)
  • RLAY 0.29
  • ETD 0.58
  • MACD
  • RLAY 0.08
  • ETD -0.04
  • Stochastic Oscillator
  • RLAY 95.97
  • ETD 28.57

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

Share on Social Networks: